| 1 |
35397003 | Alpha-SYNUCLEINOPATHY reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway. | 2022 Apr 9 |
1 |
| 2 |
32899900 | Gateways for Glutamate Neuroprotection in Parkinson's Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD. | 2020 Sep 6 |
4 |
| 3 |
28190238 | Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway. | 2018 Feb |
5 |
| 4 |
24269733 | The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. | 2014 Mar |
1 |
| 5 |
21848810 | N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast. | 2011 Oct |
1 |
| 6 |
19027885 | Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation. | 2009 Feb |
2 |
| 7 |
18957893 | Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells. | 2008 Nov |
1 |
| 8 |
11472875 | Alpha-synuclein expression is up-regulated in NTera2 cells during neuronal differentiation but unaffected by exposure to cytokines and neurotrophic factors. | 2001 Sep |
1 |
| 9 |
10654448 | Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes. | 2000 Feb |
4 |